BibTex RIS Cite

Year 2004, Volume: 2 Issue: 2, 103 - 108, 01.06.2004

Betül Sevinir

Abstract

References

  • 1. Jemal A, Tiwari RC, Murray T, et al. Cancer Statistics , 2004. CA Cancer J Clin 2004;54:8-29.
  • 2. McNikol E, Strassels S, Goudas L, et al. Nonsteroidal anti-inflammatory drugs, alone or combined with opioids, for cancer pain: A systematic review. J Clin Oncol 2004;22:1975-92.
  • 3. Longman G. Pain in paediatric oncology: Interviews with children, adolescents and their parents. Acta Paediatr 1999;88:623-30.
  • 4. Galloway KS, Yaster M. Pain and symptom control in terminally ill children. Pediatr Clin N Am 2000;47(3):711-46.
  • 5. Berde CB, Billett AL, Collins JJ. Symptom management in supportive care In: Pizzo PA, Poplack DG (eds) Principles and Practice of Pediatric Oncology. 4th edition. Philadelphia: Lippincott Williams & Wilkins; 2002. p.1301-17.
  • 6. Dangel T. Chronic pain management in children. Part I: Cancer and phantom pain. PaediatrAnaesthesia 1998;8:5-10.
  • 7. Boström B. Cancer-related pain in palliative care: patients’ perception of pain management. J Adv Nursing 2004;45:410-9.
  • 8. Collins JJ. Cancer pain management in children. European Journal of Pain 2001; 5(Suppl A):37-41.
  • 9. Katikireddi V. News:100 000 children die needlessly from cancer every year. BMJ 2004;328:422.
  • 10. Wang XS, Tang JY, Zhao M, et al. Pediatric cancer pain management practices and attitudes in China. J Pain Symptom Manage 2003;26: 748-59.
  • 11. Dougherty M, DeBaun MR. Rapid increase of morphine and benzodiazepine usage in the last three days of life in children with cancer is related to neuropathic pain. J Pediatr 2003;142:373-6.
  • 12. Hunt T. The management of pain. In: Palliative care for people with cancer. Penson J, Fisher RA (Eds). 3rd edition. London: Arnold 2002. p:9-43.
  • 13. Berde CB , Wolfe J. Pain, anxiety, distress, and suffering: Interrelated, but not interchangeable. J Pediatr 2003;142:361-3.
  • 14. Cheng KKF, Chang AQM. Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy. Cancer Nursing 2003;26:476-84.
  • 15. Kuppenheimer WG, Brown RT. Painful procedures in pediatric cancer . A comparison of interventions. Clinical Psychology Review 2002;22:753-86.
  • 16. Anghelescu D, Oakes L. Working toward better cancer pain management for children. Cancer Practice 2002;10 (Suppl 1):S52-7.
  • 17. Antunes NL. Back and neck pain in children with cancer. Pediatr Neurol 2002;27:46-8.
  • 18. Franck LS, Greenberg CS, Stevens B. Pain assessment in infants and children. Pediatr Clin N Am 2000;47(3)487-512.
  • 19. Collins JJ, Devine TD, Dick R, et al. The measurement of symptoms in young children with cancer: The validation of the memorial symptom assessment scale in children aged 7-12. J Pain Symptom Manage 2002;23: 10-6.
  • 20. Gauvain-Piquard A, Rodary C, Rezvani A, Serbouti S.The development of the DEGRR : A scale to assess pain in young children with cancer. E J Pain 1999;3:165-76.
  • 21. Miser AW, Goh TS, Dose AM, et al. Trial of a topically administered local anesthetic (EMLA cream) for pain relief during central venous port accesses in children with cancer . L Pain Symptom Manage 1994;9:259-64.
  • 22. Crock C, Olsson C, Phillips R, et al. General anaesthesia or conscious sedation for painful procedures in childhood cancer: the family’s perspective. Arch Dis Child 2003;88:253-7.
  • 23. Farrar JT, Clearly J, Rauck R, et al. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. J Natl Cancer Inst 1998;90: 611-6.
  • 24. Compton P, Athanasos P. Chronic pain, substance abuse and addiction Nurs Clin N Am 2003;525-37.
  • 25. McNikol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer related and chronic non cancer pain: A systematic review. J Pain 2003;4:231-56.
  • 26. Mercadante S. The use of anti-inflammatory drugs in cancer pain. Cancer Treat Rev 2001;27:51-61.
  • 27. Golianu B, Krane E, Galloway KS, et al. Pediatric acute pain management . Ped Clin N Am 2000;47(3):559-587.
  • 28. Flogegard H, Ljungman G. Characteristics and adequacy of intravenous morphine infusion in children in a pediatric oncology stting. Med Pediatr Oncol 2003;40:233-8.
  • 29. Hunt A, Joel S, Dick G, Goldman A. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphineas immediate – release liquid or sustained –release tablets for cancer pain. J Pediatr 1999;135:47-55.
  • 30. Wiffen P, Edwards J, Barden J, McQuay H. Oral morphine for cancer pain. Cochrane Database Syst Rev 2003;4:CD003868.
  • 31. Lawlor PG, Turner KS, Hanson J, Bruera ED. Dose ratio between morphine and methadone in patients with cancer pain. Cancer 1998;82:1167-73.
  • 32. Mercadante S. Opioid rotation for cancer pain. Rationale and clinical aspects. Cancer 1999;86.1856-66.
  • 33. Payne R, Chandler S, Einhaus M. Guidelines for the clinical use of transdermal fentanyl. Anti-Cancer Drugs 1995; 6 (Suppl 3): 50-3.
  • 34. Quigley C, Wiffen P. A systematic review of hydromorphone in acute and chronic pain. . J Pain Symptom Manage 2003;25: 169-78.
  • 35. Takahashi M, Ohara T, Yamanaka H, et al. The oral-to-intravenous equianalgesic ratio of morphine based on plasma concentrations of morphine and metabolites in advanced cancer patients receiving chronic morphine treatment. Palliat Med 2003;17:673-8.
  • 36. Fitzgibbon D, Morgan D, Dockter D,et al. In›tial pharmacokinetic, safety and efficacy evaluation of nasal morphine gluconate for breakthroug pain in cancer patients. Pain 2003;106(3):309-15.
  • 37. Kornick CA,Santiago-Palma J, Schulman G,et al. A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain. Cancer 2003;97:3121-4.
  • 38. Santiago-Palma J, Fischberg D, Kornick C, et al. Diphenhydramine as an analgesic adjuvant in refractory cancer pain. J Pain Symptom Manage 2001;22:699-703.
  • 39. Mercadante S, Ferrera P, Villari P, Arcuri E. Hyperalgesia : An emergency iatrogenic syndrome. J Pain Symptom Manage 2003;26:769-78. Bell R, Eccleston C, Kalso E.
  • 40. Caraceni A, Zecca E, Bonezzi C, et al. Gabapentin for neuropathic cancer pain: A randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 2004;22:2909-17.

Çocuklarda Kanser ve Ağrı

Year 2004, Volume: 2 Issue: 2, 103 - 108, 01.06.2004

Betül Sevinir

Abstract

Ağrı, devam eden doku zedelenmesi ve inflamasyon nedeniyle oluşan biyolojik alarmdır. Daha ileri derecede hasarların önlenmesi veya sınırlandırılmasına hizmet etmektedir. Genellikle ağrı şiddeti doku zedelenmesinin yaygınlığı ve derecesi ile bağ- lantılıdır. Bununla birlikte her ağrının koruyucu anlamı yoktur. Hem hastalığın başlangıcında hem de sonraki aflamalarda akut ve kronik ağrı çeken önemli bir grup, onkoloji hastalarıdır

References

  • 1. Jemal A, Tiwari RC, Murray T, et al. Cancer Statistics , 2004. CA Cancer J Clin 2004;54:8-29.
  • 2. McNikol E, Strassels S, Goudas L, et al. Nonsteroidal anti-inflammatory drugs, alone or combined with opioids, for cancer pain: A systematic review. J Clin Oncol 2004;22:1975-92.
  • 3. Longman G. Pain in paediatric oncology: Interviews with children, adolescents and their parents. Acta Paediatr 1999;88:623-30.
  • 4. Galloway KS, Yaster M. Pain and symptom control in terminally ill children. Pediatr Clin N Am 2000;47(3):711-46.
  • 5. Berde CB, Billett AL, Collins JJ. Symptom management in supportive care In: Pizzo PA, Poplack DG (eds) Principles and Practice of Pediatric Oncology. 4th edition. Philadelphia: Lippincott Williams & Wilkins; 2002. p.1301-17.
  • 6. Dangel T. Chronic pain management in children. Part I: Cancer and phantom pain. PaediatrAnaesthesia 1998;8:5-10.
  • 7. Boström B. Cancer-related pain in palliative care: patients’ perception of pain management. J Adv Nursing 2004;45:410-9.
  • 8. Collins JJ. Cancer pain management in children. European Journal of Pain 2001; 5(Suppl A):37-41.
  • 9. Katikireddi V. News:100 000 children die needlessly from cancer every year. BMJ 2004;328:422.
  • 10. Wang XS, Tang JY, Zhao M, et al. Pediatric cancer pain management practices and attitudes in China. J Pain Symptom Manage 2003;26: 748-59.
  • 11. Dougherty M, DeBaun MR. Rapid increase of morphine and benzodiazepine usage in the last three days of life in children with cancer is related to neuropathic pain. J Pediatr 2003;142:373-6.
  • 12. Hunt T. The management of pain. In: Palliative care for people with cancer. Penson J, Fisher RA (Eds). 3rd edition. London: Arnold 2002. p:9-43.
  • 13. Berde CB , Wolfe J. Pain, anxiety, distress, and suffering: Interrelated, but not interchangeable. J Pediatr 2003;142:361-3.
  • 14. Cheng KKF, Chang AQM. Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy. Cancer Nursing 2003;26:476-84.
  • 15. Kuppenheimer WG, Brown RT. Painful procedures in pediatric cancer . A comparison of interventions. Clinical Psychology Review 2002;22:753-86.
  • 16. Anghelescu D, Oakes L. Working toward better cancer pain management for children. Cancer Practice 2002;10 (Suppl 1):S52-7.
  • 17. Antunes NL. Back and neck pain in children with cancer. Pediatr Neurol 2002;27:46-8.
  • 18. Franck LS, Greenberg CS, Stevens B. Pain assessment in infants and children. Pediatr Clin N Am 2000;47(3)487-512.
  • 19. Collins JJ, Devine TD, Dick R, et al. The measurement of symptoms in young children with cancer: The validation of the memorial symptom assessment scale in children aged 7-12. J Pain Symptom Manage 2002;23: 10-6.
  • 20. Gauvain-Piquard A, Rodary C, Rezvani A, Serbouti S.The development of the DEGRR : A scale to assess pain in young children with cancer. E J Pain 1999;3:165-76.
  • 21. Miser AW, Goh TS, Dose AM, et al. Trial of a topically administered local anesthetic (EMLA cream) for pain relief during central venous port accesses in children with cancer . L Pain Symptom Manage 1994;9:259-64.
  • 22. Crock C, Olsson C, Phillips R, et al. General anaesthesia or conscious sedation for painful procedures in childhood cancer: the family’s perspective. Arch Dis Child 2003;88:253-7.
  • 23. Farrar JT, Clearly J, Rauck R, et al. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients. J Natl Cancer Inst 1998;90: 611-6.
  • 24. Compton P, Athanasos P. Chronic pain, substance abuse and addiction Nurs Clin N Am 2003;525-37.
  • 25. McNikol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer related and chronic non cancer pain: A systematic review. J Pain 2003;4:231-56.
  • 26. Mercadante S. The use of anti-inflammatory drugs in cancer pain. Cancer Treat Rev 2001;27:51-61.
  • 27. Golianu B, Krane E, Galloway KS, et al. Pediatric acute pain management . Ped Clin N Am 2000;47(3):559-587.
  • 28. Flogegard H, Ljungman G. Characteristics and adequacy of intravenous morphine infusion in children in a pediatric oncology stting. Med Pediatr Oncol 2003;40:233-8.
  • 29. Hunt A, Joel S, Dick G, Goldman A. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphineas immediate – release liquid or sustained –release tablets for cancer pain. J Pediatr 1999;135:47-55.
  • 30. Wiffen P, Edwards J, Barden J, McQuay H. Oral morphine for cancer pain. Cochrane Database Syst Rev 2003;4:CD003868.
  • 31. Lawlor PG, Turner KS, Hanson J, Bruera ED. Dose ratio between morphine and methadone in patients with cancer pain. Cancer 1998;82:1167-73.
  • 32. Mercadante S. Opioid rotation for cancer pain. Rationale and clinical aspects. Cancer 1999;86.1856-66.
  • 33. Payne R, Chandler S, Einhaus M. Guidelines for the clinical use of transdermal fentanyl. Anti-Cancer Drugs 1995; 6 (Suppl 3): 50-3.
  • 34. Quigley C, Wiffen P. A systematic review of hydromorphone in acute and chronic pain. . J Pain Symptom Manage 2003;25: 169-78.
  • 35. Takahashi M, Ohara T, Yamanaka H, et al. The oral-to-intravenous equianalgesic ratio of morphine based on plasma concentrations of morphine and metabolites in advanced cancer patients receiving chronic morphine treatment. Palliat Med 2003;17:673-8.
  • 36. Fitzgibbon D, Morgan D, Dockter D,et al. In›tial pharmacokinetic, safety and efficacy evaluation of nasal morphine gluconate for breakthroug pain in cancer patients. Pain 2003;106(3):309-15.
  • 37. Kornick CA,Santiago-Palma J, Schulman G,et al. A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain. Cancer 2003;97:3121-4.
  • 38. Santiago-Palma J, Fischberg D, Kornick C, et al. Diphenhydramine as an analgesic adjuvant in refractory cancer pain. J Pain Symptom Manage 2001;22:699-703.
  • 39. Mercadante S, Ferrera P, Villari P, Arcuri E. Hyperalgesia : An emergency iatrogenic syndrome. J Pain Symptom Manage 2003;26:769-78. Bell R, Eccleston C, Kalso E.
  • 40. Caraceni A, Zecca E, Bonezzi C, et al. Gabapentin for neuropathic cancer pain: A randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 2004;22:2909-17.
There are 40 citations in total.

Details

Primary Language Turkish
Journal Section Collection
Authors

Betül Sevinir This is me

Publication Date June 1, 2004
Published in Issue Year 2004 Volume: 2 Issue: 2

Cite

APA Sevinir, B. (2004). Çocuklarda Kanser ve Ağrı. Güncel Pediatri, 2(2), 103-108.
AMA Sevinir B. Çocuklarda Kanser ve Ağrı. Güncel Pediatri. June 2004;2(2):103-108.
Chicago Sevinir, Betül. “Çocuklarda Kanser Ve Ağrı”. Güncel Pediatri 2, no. 2 (June 2004): 103-8.
EndNote Sevinir B (June 1, 2004) Çocuklarda Kanser ve Ağrı. Güncel Pediatri 2 2 103–108.
IEEE B. Sevinir, “Çocuklarda Kanser ve Ağrı”, Güncel Pediatri, vol. 2, no. 2, pp. 103–108, 2004.
ISNAD Sevinir, Betül. “Çocuklarda Kanser Ve Ağrı”. Güncel Pediatri 2/2 (June 2004), 103-108.
JAMA Sevinir B. Çocuklarda Kanser ve Ağrı. Güncel Pediatri. 2004;2:103–108.
MLA Sevinir, Betül. “Çocuklarda Kanser Ve Ağrı”. Güncel Pediatri, vol. 2, no. 2, 2004, pp. 103-8.
Vancouver Sevinir B. Çocuklarda Kanser ve Ağrı. Güncel Pediatri. 2004;2(2):103-8.